U.S., EU investigate link between Raptiva, brain disease

02/19/2009 | Bloomberg · Los Angeles Times (tiered subscription model)

The FDA and the European Medicines Agency are investigating a possible link between Genentech's psoriasis drug Raptiva and progressive multifocal leukoencephalopathy, a deadly brain infection. The agencies received three reports of deaths and one possible case of the disease. Genentech and its European partner Merck KGaA said they are working with the regulators to address the issue.

View Full Article in:

Bloomberg · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations